Business Services Industry

Some GlaxoSmithKline Shareholders Are Wary of CEO's Performance Targets.

Knight Ridder/Tribune Business News, May, 2004

Daily Mail, London Knight Ridder/Tribune Business News

May 18--Sir Christopher Hogg can bail out from GlaxoSmithKline on a brighter note when, as expected, he makes way for another Sir Christopher.

At this year's agm it was the anti-vivisection brigade not the big battalion shareholders that made the waves. This does not mean all is rosy in GSK's garden.

There are still severe doubts among a substantial minority of investors over lax performance targets for Jean-Pierre Garnier and those at the top, and the possibility of unlimited gains.

This might not be felt so strongly were the shares to pick up some momentum. But they still trail much of the FTSE. Sir Chris Gent will face a daunting task.

To see more of the Daily...

Premium Content Partnership | HighBeam Research provides an in-depth online archive library of reference works. HighBeam Research
 

BNET TalkbackShare your ideas and expertise on this topic

Please add your comment:

  1. You are currently: a Guest |
  2.  

Basic HTML tags that work in comments are: bold (<b></b>), italic (<i></i>), underline (<u></u>), and hyperlink (<a href></a)

advertisement
Click Here
advertisement
  • Click Here
  • Click Here
  • Click Here
advertisement